TRINEO by

TRISMEGISTUS-PHARMACORE ☥

NEUROAMPHECINE-HERICEN™ (NAH)

Alchemy for the Mind

What is NAH? A novel cleavable prodrug that covalently links a CNS stimulant pharmacophore with a potent neurotrophic factor inducer (derived from Hericium erinaceus). Once in the body, NAH undergoes controlled enzymatic cleavage to release both payloads with tunable kinetics.

Dual-Action Mechanism

  • Phase 1 (Acute – 0–4 hrs): Rapid release of stimulant moiety → ↑ dopamine & norepinephrine → laser focus, motivation, and executive function.

  • Phase 2 (Sustained – 4–24+ hrs): Release of erinacine/hericenone scaffold → ↑ NGF & BDNF → neurite outgrowth, synaptic plasticity, and neuroregeneration.

Target Indications

  • Attention-Deficit/Hyperactivity Disorder (ADHD/ADD)

  • Mild Cognitive Impairment & early neurodegenerative conditions

  • Healthy cognitive optimization (performance neurology)

Key Advantages

  • Single daily dose (no polypharmacy)

  • Built-in neuroprotection – not just symptom masking

  • Tunable release via proprietary linker technology

  • Potential for improved long-term brain health

Development Stage Provisional patent filed April 11, 2026 Detailed synthesis protocol validated in specification IND-enabling studies planned 2026–2027

Trismegistus Pharma – Founded by inventor Robert Caldwell Robertson III

Confidential – For Qualified Investors & Researchers Only

3. MISSION & VISION STATEMENT (About Us Page)

Our Mission To unlock human cognitive potential by creating medicines that do not merely treat symptoms — they rebuild the brain from within.

Our Vision A world where cognitive decline is optional, where focus is effortless, and where the ancient wisdom of nature’s neurotrophics is fused with modern pharmacology under the banner of Trismegistus — the thrice-great master of transformation.

Founding Story Born from the vision of inventor Robert Caldwell Robertson III, Trismegistus Pharma was created to bring NEUROAMPHECINE-HERICEN from provisional patent to patients who need it most.

CROSSW GENE THERAPY FOR FRAGILE X SYNDROME

POTENTIALLY THE CURE FOR FRAGILE X SYNDROME

TRISMEGISTUS PHARMACORE IS WORKING ON THE GENE THERAPY TO REPAIR THE DAMAGED X CHROMSOME IN PATIENTS WITH FRAGILE X SYNDROME.

USING A SMALLPIECE OF THE DEVELOPERS OWN X CHROMOSOME -REPLICATED AND READY TO BE FITTED TO THE DAMAGED X CHROMOSOME THROUGH GENE THERAPEUTIC CHANNELS.

TREATMENT SHOULD TAKE ABOUT A WEEK WITH RELEAF OF MANY SYMPTOMS OF THE DISORDER WITHIN 1-3 YEARS.

DJED PILLAR PROTOCOL

BY R.C. ROBERTSON III

SCIENTIFIC SPINAL REGENERATION FRAMEWORK

A research‑aligned, multi‑system model for supporting spinal structure, signaling, and repair

1. Structural Matrix Restoration (Collagen, Proteoglycans, Mineralization)

This section focuses on the tissues that make up vertebrae, discs, ligaments, and fascia.

A. Collagen Synthesis Pathway

Researchers focus on:

  • Vitamin C–dependent hydroxylation — essential for stable collagen cross‑linking

  • Glycine, proline, hydroxyproline availability — core building blocks

  • Copper‑dependent lysyl oxidase — stabilizes collagen fibrils

  • Manganese and zinc cofactors — required for matrix enzymes

B. Intervertebral Disc Support

Disc health research emphasizes:

  • Proteoglycan synthesis (aggrecan, decorin)

  • Hydration gradients

  • Anti‑inflammatory modulation

C. Bone Remodeling

Bone is constantly rebuilt through:

  • Osteoblast activity — formation

  • Osteoclast regulation — resorption

  • Calcium–phosphate matrix deposition

2. Nutritional Inputs Supporting Tissue Repair

This is where your bone‑broth emphasis fits into a scientific frame.

A. Collagen‑Relevant Nutrition

Bone broth contains:

  • Gelatin (denatured collagen)

  • Glycine, proline

  • Minerals (varies widely by preparation)

Research often uses collagen peptides, which have more predictable concentrations.

B. Nutrients Studied for Spinal Tissue Support

  • Vitamin C — collagen cross‑linking

  • Omega‑3 fatty acids — inflammation modulation

  • Magnesium — neuromuscular stability

  • Vitamin D — calcium absorption

  • Calcium and phosphorus — mineral matrix

  • Protein intake — amino acid supply

3. Hormonal & Growth‑Factor Regulation

This is NOT a prescription — it is a map of the systems scientists study.

A. Anabolic Hormones

  • Growth hormone (GH) — stimulates IGF‑1

  • IGF‑1 — promotes bone and connective‑tissue formation

  • Testosterone — increases bone density

  • Estrogen — protects bone remodeling

B. Calcium‑Regulating Hormones

  • Parathyroid hormone (PTH) — regulates calcium release

  • Calcitonin — counterbalances PTH

C. Catabolic Hormones

  • Cortisol — chronic elevation weakens bone and collagen

Researchers aim to optimize anabolic–catabolic balance, not push any hormone in isolation.

4. Neural & Vascular Support for Spinal Healing

Spinal tissue repair depends on:

  • Blood flow — nutrient delivery

  • Nerve health — B‑vitamins, metabolic stability

  • Mitochondrial function — energy for repair processes

5. Biomechanical Reinforcement

Tissue cannot regenerate effectively without proper mechanical conditions.

A. Stabilizing Muscle Systems

  • Transverse abdominis

  • Multifidus

  • Gluteal complex

These muscles reduce shear forces on the spine.

B. Load‑Bearing Principles

  • Axial loading stimulates bone formation

  • Controlled movement improves disc hydration

  • Avoiding chronic flexion reduces disc stress

6. Inflammation & Immune Modulation

Chronic inflammation impairs collagen and disc health.

Research focuses on:

  • Cytokine pathways

  • Omega‑3 fatty acids

  • Polyphenols

  • Gut microbiome

SYNTHESIS: The Scientific “Treatment Plan” Model

This is a systems‑level framework, not a personal protocol.

SystemScientific TargetResearch FocusStructural MatrixCollagen, proteoglycans, mineralizationVitamin C, amino acids, mineralsHormonal SignalingGH/IGF‑1, sex hormones, PTH/calcitoninAnabolic–catabolic balanceNeural/VascularBlood flow, nerve healthB‑vitamins, mitochondrial supportBiomechanicsStabilization, load distributionCore musculature, axial loadingInflammationCytokine modulationOmega‑3s, polyphenols, microbiome